Athena Diagnostics - Home - Advanced diagnostic testing ...
Letter of Medical Necessity Charcot-Marie-Tooth Disease (CMT) Advanced Evaluation—Comprehensive FORMTEXT <Date>ATTN: FORMTEXT <Medical Director/ Physician Name>, MD FORMTEXT <Institution/Insurance Company> FORMTEXT <Street Address> FORMTEXT <City>, FORMTEXT <State> FORMTEXT <Zip>RE: FORMTEXT <Patient Name>DOB: FORMTEXT <MM/DD/YYYY>Member ID: FORMTEXT <Insurance ID Number>Group #: FORMTEXT <Enter Group #>Dear Medical Director:I am writing on behalf of my patient FORMTEXT <Patient Name> to request coverage for the Charcot-Marie-Tooth Disease (CMT) Advanced Evaluation – Comprehensive test. I have determined that this test is medically necessary because of the following aspects of my patient’s history: FORMTEXT <Patient Name> is a FORMTEXT <age> -year-old FORMTEXT <gender > with a suspected diagnosis of CMT due to the following symptoms and clinical findings:1. FORMTEXT <Symptom #1 with ICD-9 code>2. FORMTEXT <Symptom #2 with ICD-9 code>3. FORMTEXT <Symptom #3 with ICD-9 code>< Add additional details if relevant > The patient’s family history of polyneuropathy is <negative or unknown; add additional details if relevant>. <Select one: The findings of electromyography and nerve conduction velocity studies are uninformative; or electrodiagnostic testing was not performed (specify reasons not performed)>. Additionally, all other metabolic, infectious, autoimmune, and toxic etiologies have been ruled out. The lack of a specific etiology suggests that genetic testing may help diagnose the cause of the polyneuropathy.Rationale for TestingCMT, the most common inherited peripheral neuropathy, comprises a group of chronic motor and sensory polyneuropathies that may manifest with distal muscle weakness and atrophy, mild to moderate sensory loss, depressed tendon reflexes, and high arched feet (pes cavus). The clinical diagnosis is generally based on the findings of physical examination, electromyography (EMG), nerve conduction velocity (NCV) testing, and family history. Genetic testing is useful for accurate diagnosis and classification of hereditary forms of polyneuropathy such as CMT.PFJlZm1hbj48Q2l0ZT48QXV0aG9yPkhpcm9zZTwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN REFMGR.CITE PFJlZm1hbj48Q2l0ZT48QXV0aG9yPkhpcm9zZTwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN EN.CITE.DATA 1 Testing for the underlying genetic aberration is complicated by the large number of genes associated with CMT and the heterogeneity of the disease. Mutations in at least 28 genes have been associated with CMT.1 Traditional Sanger sequencing-based detection of individual mutations can be time consuming and costly when testing for mutations in large numbers of genes. Next-generation sequencing (NGS), on the other hand, allows sequencing of numerous genes simultaneously. Thus, NGS targeted at disease-associated genes seems appropriate for detecting mutations in disorders with a highly heterogeneous genetic background, such as CMT. Because the frequency of specific mutations varies with inheritance pattern, phenotype, and electrodiagnostic findings, these features are used to guide the selection of genetic tests.1 The CMT Advanced Evaluation—Comprehensive test is designed to identify the genetic cause of CMT in patients whose family history is negative or not available (possibly due to mild subclinical expression, autosomal recessive inheritance, or de novo mutation) or in whom electrodiagnostic testing is contraindicated, refused, or uninformative. This test begins with multiplex ligation-dependent probe amplification (MLPA) to detect the most common genetic cause of CMT (PMP22 duplication or deletion). If MPLA results are negative, NGS is performed to detect mutations in 23 genes that have been associated with CMT; mutations identified by NGS will be confirmed by Sanger sequencing. The genes evaluated and the targeted exome approach are based on the American Academy of Neurology (AAN) practice parameter1 and the American College of Medical Genetics guidelines. PFJlZm1hbj48Q2l0ZT48QXV0aG9yPkhpcm9zZTwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN REFMGR.CITE PFJlZm1hbj48Q2l0ZT48QXV0aG9yPkhpcm9zZTwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN EN.CITE.DATA 2 Results from the test will be used to confirm the diagnosis of CMT in this patient and to guide appropriate medical care. Specifically, the results may:Inform treatment decisions; for example: Selection of appropriate treatment options.PFJlZm1hbj48Q2l0ZT48QXV0aG9yPkhpcm9zZTwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl
Y051bT4xMDwvUmVjTnVtPjxJRFRleHQ+U0NOMUEgdGVzdGluZyBmb3IgZXBpbGVwc3k6IGFwcGxp
Y2F0aW9uIGluIGNsaW5pY2FsIHByYWN0aWNlPC9JRFRleHQ+PE1ETCBSZWZfVHlwZT0iSm91cm5h
bCI+PFJlZl9UeXBlPkpvdXJuYWw8L1JlZl9UeXBlPjxSZWZfSUQ+MTA8L1JlZl9JRD48VGl0bGVf
UHJpbWFyeT5TQ04xQSB0ZXN0aW5nIGZvciBlcGlsZXBzeTogYXBwbGljYXRpb24gaW4gY2xpbmlj
YWwgcHJhY3RpY2U8L1RpdGxlX1ByaW1hcnk+PEF1dGhvcnNfUHJpbWFyeT5IaXJvc2UsUy48L0F1
dGhvcnNfUHJpbWFyeT48QXV0aG9yc19QcmltYXJ5PlNjaGVmZmVyLEkuRS48L0F1dGhvcnNfUHJp
bWFyeT48QXV0aG9yc19QcmltYXJ5Pk1hcmluaSxDLjwvQXV0aG9yc19QcmltYXJ5PjxBdXRob3Jz
X1ByaW1hcnk+RGUsSm9uZ2hlIFAuPC9BdXRob3JzX1ByaW1hcnk+PEF1dGhvcnNfUHJpbWFyeT5B
bmRlcm1hbm4sRS48L0F1dGhvcnNfUHJpbWFyeT48QXV0aG9yc19QcmltYXJ5PkdvbGRtYW4sQS5N
LjwvQXV0aG9yc19QcmltYXJ5PjxBdXRob3JzX1ByaW1hcnk+S2F1ZmZtYW4sTS48L0F1dGhvcnNf
UHJpbWFyeT48QXV0aG9yc19QcmltYXJ5PlRhbixOLkMuPC9BdXRob3JzX1ByaW1hcnk+PEF1dGhv
cnNfUHJpbWFyeT5Mb3dlbnN0ZWluLEQuSC48L0F1dGhvcnNfUHJpbWFyeT48QXV0aG9yc19Qcmlt
YXJ5PlNpc29kaXlhLFMuTS48L0F1dGhvcnNfUHJpbWFyeT48QXV0aG9yc19QcmltYXJ5Pk90dG1h
bixSLjwvQXV0aG9yc19QcmltYXJ5PjxBdXRob3JzX1ByaW1hcnk+QmVya292aWMsUy5GLjwvQXV0
aG9yc19QcmltYXJ5PjxEYXRlX1ByaW1hcnk+MjAxMy81PC9EYXRlX1ByaW1hcnk+PEtleXdvcmRz
PmRpYWdub3NpczwvS2V5d29yZHM+PEtleXdvcmRzPkVwaWxlcHN5PC9LZXl3b3Jkcz48S2V5d29y
ZHM+R2VuZXM8L0tleXdvcmRzPjxLZXl3b3Jkcz5HZW5ldGljIFByZWRpc3Bvc2l0aW9uIHRvIERp
c2Vhc2U8L0tleXdvcmRzPjxLZXl3b3Jkcz5HZW5ldGljIFRlc3Rpbmc8L0tleXdvcmRzPjxLZXl3
b3Jkcz5nZW5ldGljczwvS2V5d29yZHM+PEtleXdvcmRzPkh1bWFuczwvS2V5d29yZHM+PEtleXdv
cmRzPkluZmFudDwvS2V5d29yZHM+PEtleXdvcmRzPk11dGF0aW9uPC9LZXl3b3Jkcz48S2V5d29y
ZHM+TkFWMS4xIFZvbHRhZ2UtR2F0ZWQgU29kaXVtIENoYW5uZWw8L0tleXdvcmRzPjxLZXl3b3Jk
cz5QaGVub3R5cGU8L0tleXdvcmRzPjxSZXByaW50Pk5vdCBpbiBGaWxlPC9SZXByaW50PjxTdGFy
dF9QYWdlPjk0NjwvU3RhcnRfUGFnZT48RW5kX1BhZ2U+OTUyPC9FbmRfUGFnZT48UGVyaW9kaWNh
bD5FcGlsZXBzaWE8L1BlcmlvZGljYWw+PFZvbHVtZT41NDwvVm9sdW1lPjxJc3N1ZT41PC9Jc3N1
ZT48TWlzY18zPjEwLjExMTEvZXBpLjEyMTY4IFtkb2ldPC9NaXNjXzM+PEFkZHJlc3M+RGVwYXJ0
bWVudCBvZiBQZWRpYXRyaWNzIGFuZCBSZXNlYXJjaCBJbnN0aXR1dGUgZm9yIHRoZSBNb2xlY3Vs
YXIgUGF0aG9tZWNoYW5pc21zIG9mIEVwaWxlcHN5LCBGdWt1b2thIFVuaXZlcnNpdHksIEZ1a3Vv
a2EsIEphcGFuLiBoaXJvc2VAZnVrdW9rYS11LmFjLmpwPC9BZGRyZXNzPjxXZWJfVVJMPlBNOjIz
NTg2NzAxPC9XZWJfVVJMPjxaWl9Kb3VybmFsU3RkQWJicmV2PjxmIG5hbWU9IlN5c3RlbSI+RXBp
bGVwc2lhPC9mPjwvWlpfSm91cm5hbFN0ZEFiYnJldj48WlpfV29ya2Zvcm1JRD4xPC9aWl9Xb3Jr
Zm9ybUlEPjwvTURMPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlN0ZW5ob3VzZTwvQXV0aG9yPjxZZWFy
PjIwMTM8L1llYXI+PFJlY051bT4xMTwvUmVjTnVtPjxJRFRleHQ+U0NOMUEgR2VuZXRpYyBUZXN0
IGZvciBEcmF2ZXQgU3luZHJvbWUgKFNldmVyZSBNeW9jbG9uaWMgRXBpbGVwc3kgb2YgSW5mYW5j
eSBhbmQgaXRzIENsaW5pY2FsIFN1YnR5cGVzKSBmb3IgdXNlIGluIHRoZSBEaWFnbm9zaXMsIFBy
b2dub3NpcywgVHJlYXRtZW50IGFuZCBNYW5hZ2VtZW50IG9mIERyYXZldCBTeW5kcm9tZTwvSURU
ZXh0PjxNREwgUmVmX1R5cGU9IkpvdXJuYWwiPjxSZWZfVHlwZT5Kb3VybmFsPC9SZWZfVHlwZT48
UmVmX0lEPjExPC9SZWZfSUQ+PFRpdGxlX1ByaW1hcnk+U0NOMUEgR2VuZXRpYyBUZXN0IGZvciBE
cmF2ZXQgU3luZHJvbWUgKFNldmVyZSBNeW9jbG9uaWMgRXBpbGVwc3kgb2YgSW5mYW5jeSBhbmQg
aXRzIENsaW5pY2FsIFN1YnR5cGVzKSBmb3IgdXNlIGluIHRoZSBEaWFnbm9zaXMsIFByb2dub3Np
cywgVHJlYXRtZW50IGFuZCBNYW5hZ2VtZW50IG9mIERyYXZldCBTeW5kcm9tZTwvVGl0bGVfUHJp
bWFyeT48QXV0aG9yc19QcmltYXJ5PlN0ZW5ob3VzZSxTLkEuPC9BdXRob3JzX1ByaW1hcnk+PEF1
dGhvcnNfUHJpbWFyeT5FbGxpcyxSLjwvQXV0aG9yc19QcmltYXJ5PjxBdXRob3JzX1ByaW1hcnk+
WnViZXJpLFMuPC9BdXRob3JzX1ByaW1hcnk+PERhdGVfUHJpbWFyeT4yMDEzPC9EYXRlX1ByaW1h
cnk+PEtleXdvcmRzPmRpYWdub3NpczwvS2V5d29yZHM+PEtleXdvcmRzPkVwaWxlcHN5PC9LZXl3
b3Jkcz48S2V5d29yZHM+R2VuZXRpYyBUZXN0aW5nPC9LZXl3b3Jkcz48S2V5d29yZHM+SW5mYW50
PC9LZXl3b3Jkcz48S2V5d29yZHM+TXV0YXRpb248L0tleXdvcmRzPjxLZXl3b3Jkcz5QaGVub3R5
cGU8L0tleXdvcmRzPjxLZXl3b3Jkcz5Qcm9nbm9zaXM8L0tleXdvcmRzPjxLZXl3b3Jkcz5TeW5k
cm9tZTwvS2V5d29yZHM+PFJlcHJpbnQ+Tm90IGluIEZpbGU8L1JlcHJpbnQ+PFBlcmlvZGljYWw+
UExvUy5DdXJyLjwvUGVyaW9kaWNhbD48Vm9sdW1lPjU8L1ZvbHVtZT48VXNlcl9EZWZfNT5QTUMz
NjQ0Mjk4PC9Vc2VyX0RlZl81PjxNaXNjXzM+MTAuMTM3MS9jdXJyZW50cy5lb2d0LmM1NTNiODNk
NzQ1ZGQ3OWJmYjYxZWFmMzVlNTIyYjBiIFtkb2ldPC9NaXNjXzM+PEFkZHJlc3M+U2NpZW50aWZp
YyBBZHZpc29yIFVLIEdlbmV0aWMgVGVzdGluZyBOZXR3b3JrPC9BZGRyZXNzPjxXZWJfVVJMPlBN
OjIzNjUzMzQ4PC9XZWJfVVJMPjxaWl9Kb3VybmFsU3RkQWJicmV2PjxmIG5hbWU9IlN5c3RlbSI+
UExvUy5DdXJyLjwvZj48L1paX0pvdXJuYWxTdGRBYmJyZXY+PFpaX1dvcmtmb3JtSUQ+MTwvWlpf
V29ya2Zvcm1JRD48L01ETD48L0NpdGU+PC9SZWZtYW4+
ADDIN REFMGR.CITE PFJlZm1hbj48Q2l0ZT48QXV0aG9yPkhpcm9zZTwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN EN.CITE.DATA 4,5Avoidance of medications that are 1) contraindicated because they could exacerbate symptoms3; or 2) likely to be ineffective (eg, immunotherapy for autoimmune peripheral neuropathy, which may present with features suggestive of CMT).Help avoid a long series of laborious and potentially costly diagnostic procedures. Provide information useful for family planning.The reflex test approach could minimize the cost of testing by looking for the most common genetic cause of CMT (PMP22 duplication/deletion) first, as described in the AAN practice parameter.1In summary, I am requesting that FORMTEXT <Patient Name> be approved for the CMT Advanced Evaluation—Comprehensive test : test code 4001 offered by Athena Diagnostics. The CPT code for Step 1 is 81324. The CPT codes for Step 2, performed if the results of MPLA are negative, are 81325, 81403, 81404 (x3), 81405 (x5), 81406 (x5), and 81479. I hope you will support my decision to perform CMT genetic testing for this patient. Please feel free to contact me at FORMTEXT <Physician Phone> if you have additional questions.Sincerely, FORMTEXT <Physician Name>, MDNPI #: FORMTEXT <Physician NPI#>Contact information: FORMTEXT < Address> FORMTEXT <City>, FORMTEXT <State> FORMTEXT <Zip>Contact Phone No.: FORMTEXT <phone number>References ADDIN REFMGR.REFLIST 1. England JD, Gronseth GS, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72:185-192. 2. ACMG Board of Directors. Points to consider in the clinical application of genomic sequencing. Genet Med. 2012;14:759-761.3. Weimer LH, Podwall D. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease. J Neurol Sci. 2006;242:47-54.4. Casasnovas C, Cano LM, Alberti A, et al. Charcot-Marie-tooth disease. Foot Ankle Spec. 2008;1:350-354.5. Chan G, Bowen JR, Kumar SJ. Evaluation and treatment of hip dysplasia in Charcot-Marie-Tooth disease. Orthop Clin North Am. 2006;37:203-209, vii. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- home blood type testing kit
- testing home for meth residue
- diagnostic testing for myocardial infarction
- meth testing home inspection
- home urine alcohol testing kits
- quest diagnostics std testing cost
- water testing strips home depot
- home health testing kits
- home drug testing kits reviews
- best home drug testing kits
- quest diagnostics drug testing procedures
- best home drug testing kits for marijuana